Fig. 2.
Results from 36 HER2/neu-positive patients treated with 1 year sequential trastuzumab after chemotherapy (green line) as compared to a historical patient sample of 35 patients not receiving trastuzumab therapy (red line)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.